Discover verified firmographic data, deep technology stacks, capital funding trajectories, and decision-maker telemetry to power autonomous B2B sales outreach.
Displaying page 58 of 812
Advanced Manufacturing. Energy. Environment. Water. For more than 70 years, OBG has specialized in engineering and problem solving, but our real strength is creating comprehensive, integrated solutions for our clients. OBG Theres a way.
OBG: Der leistungsfähige Komplettanbieter für anspruchsvolle Bauvorhaben. Als Ottweiler Baugesellschaft im Jahr 1963 gegründet, haben wir uns in den folgenden Jahrzehnten zu einem Full-Service-Dienstleister rund um das Thema Planen und Bauen entwickelt. Mittelständisch geprägt und familiengeführt verbindet die Dachmarke OBG derzeit viele Spezialisten in Luxemburg, Rheinland-Pfalz sowie im Rhein-Main und im Saarland. Mit OBG Planen und Bauen heißt: Von der Entwicklung über die Planung, der Bauausführung bis hin zum Betrieb erbringen wir alle Leistungen aus einer Hand. OBG: Ein starkes Fundament für Deine Karriere. Seit 60 Jahren pflegen wir unsere Unternehmenskultur, die auf traditionellen und zeitlosen Werten wie Ehrlichkeit, Zuverlässigkeit, Glaubwürdigkeit und dem Versprechen "Ein Wort ist ein Wort" fußt. Egal ob Praktikanten, Werkstudenten, Berufseinsteiger oder langjährige Mitarbeiter (jeweils m/w/d) - derzeit vertrauen uns über 800 Mitarbeiter in mehr als 100 verschiedenen Berufen. Wir fordern und fördern jeden Einzelnen von ihnen individuell, aufgrund seiner Persönlichkeit und seinen individuellen Stärken. Unabhängig von Alter, Geschlecht, Religion oder Herkunft, wer uns von seiner Leidenschaft überzeugt, dem schenken wir unser Vertrauen. Informier Dich jetzt über Deine Einstiegsmöglichkeit bei OBG: https://www.obg-gruppe.de/2928/Karriere/Stellenangebote Impressum Verantwortlich für den Inhalt ist die OBG Gruppe Illinger Straße 150 66564 Ottweiler Tel.: 06824 3000 30-0 Fax: 06824 3000 30-99 E-Mail: info@obg-gruppe.de Sitz: Ottweiler Amtsgericht Saarbrücken HRB 101546 Finanzamt Neunkirchen Umsatzsteuer-Ident-Nr.: DE 251484296 Geschäftsführer: Dipl.-Ing. Jürgen Raber Dipl.-Ing. (FH) Michael Härer Datenschutz: https://www.obg-gruppe.de/datenschutz
Obgyn Associate PC is a financial services company based out of 1709 Union Ave, Natrona Heights, Pennsylvania, United States.
Houston’s Premier OB/GYN: Striving for excellence and seeking improvement is our constant pursuit The physicians at OB/GYN Care work cooperatively to offer the best possible care for women from puberty through menopause. We provide comprehensive obstetrical and gynecological care from routine check ups to emergency procedures. We are committed to offering only superior health care and experiences of exceptional quality and excellence. We practice only the best medicine, educating our patients and ourselves continuously. At OB/GYN Care we believe in treating others as we would have them treat us. We are empathetic and compassionate and we recognize that each person is unique and valuable.
Vi er en specialiseret rådgivende ingeniørvirksomhed, der er sat i verden for at skabe bedre rammer om menneskers liv, læring og arbejde. Derfor beskæftiger vi os med de vigtigste typer bygninger for de fleste: boliger, institutioner og arbejdspladser.
Comprehensive enterprise dossier available in global intelligence registry.
OBI was founded in 1995 and combines the considerable experience gained in multi-national accounting practices with the personalised service of a smaller firm. The partners are supported by a team of experienced service providers, giving timely and personalised service at competitive costs. Adapting to change and responding to challenges are second nature. The availability of client service partners, continuity of service managers and staff to clients, on an ongoing basis, gives the firm many advantages. A hallmark of the firm is the quick, flexible and innovative response to our client's needs with the result that our clients enjoy a competitive edge in today's economy.
OBI was founded in 1995 and combines the considerable experience gained in multi-national accounting practices with the personalised service of a smaller firm. The partners are supported by a team of experienced service providers, giving timely and personalised service at competitive costs. Adapting to change and responding to challenges are second nature. The availability of client service partners, continuity of service managers and staff to clients, on an ongoing basis, gives the firm many advantages. A hallmark of the firm is the quick, flexible and innovative response to our client's needs with the result that our clients enjoy a competitive edge in today's economy.
OBI Pharma Inc. (OBI) is a global clinical stage oncology company that is headquartered in Taiwan. The company also has subsidiaries in the United States and Australia. It was founded in 2002 by Dr. Michael Chang, an accomplished biotech entrepreneur in the United States. Its stocks were issued publicly in 2012. Subsequently, the company was successfully listed on the Taipei Exchange (4174.TWO) in 2015. OBI focuses on innovative research and development for cancer therapies and aims to develop “first-in-class” and “best-in-class” ground-breaking drugs. It aspires to market these drugs worldwide with a “Made in Taiwan” branding and to provide new treatment options for patients with unmet medical needs. The core value of OBI lies in its passion to develop and deliver a portfolio of unique antibody-drug conjugates (ADC) drugs for patients, in addition to its promising Globo series (e.g., Globo H) of cancer therapeutic vaccines. This evolving portfolio includes a spectrum of cancer targets, such as TROP2, Nectin4, HER2, etc. These ADCs are built based on two distinct ADC technology platforms, each with different characteristics. Both platforms are customizable and offer a “plug-and-play” advantage through a specialized site-specific conjugation using a proprietary enzyme. With the added value of scalability, these “plug-and-play” technology platforms enable ADC development to be relatively simple and efficient. OBI is interested in commercializing its ADC technology platforms and looks forward to collaborating with biotech and pharmaceutical companies by enabling “first-in-class” and “best-in-class” therapeutic candidates for further development.
OBI Pharma Inc. (OBI) is a global clinical stage oncology company that is headquartered in Taiwan. The company also has subsidiaries in the United States and Australia. It was founded in 2002 by Dr. Michael Chang, an accomplished biotech entrepreneur in the United States. Its stocks were issued publicly in 2012. Subsequently, the company was successfully listed on the Taipei Exchange (4174.TWO) in 2015. OBI focuses on innovative research and development for cancer therapies and aims to develop “first-in-class” and “best-in-class” ground-breaking drugs. It aspires to market these drugs worldwide with a “Made in Taiwan” branding and to provide new treatment options for patients with unmet medical needs. The core value of OBI lies in its passion to develop and deliver a portfolio of unique antibody-drug conjugates (ADC) drugs for patients, in addition to its promising Globo series (e.g., Globo H) of cancer therapeutic vaccines. This evolving portfolio includes a spectrum of cancer targets, such as TROP2, Nectin4, HER2, etc. These ADCs are built based on two distinct ADC technology platforms, each with different characteristics. Both platforms are customizable and offer a “plug-and-play” advantage through a specialized site-specific conjugation using a proprietary enzyme. With the added value of scalability, these “plug-and-play” technology platforms enable ADC development to be relatively simple and efficient. OBI is interested in commercializing its ADC technology platforms and looks forward to collaborating with biotech and pharmaceutical companies by enabling “first-in-class” and “best-in-class” therapeutic candidates for further development.
#JesteśmyOBI czyli międzynarodową firmą o 50-letniej tradycji w branży DIY. W Europie zarządzamy łącznie 660 marketami, w tym w Polsce jest ich 61, zlokalizowanych w 41 miastach. Jako lider rynku artykułów budowlanych, swój sukces zawdzięczamy przede wszystkim ludziom tworzącym OBI. To dzięki nim możemy pochwalić się stałym rozwojem firmy, zorientowanym na potrzeby Klientów, w zakresie asortymentu i usług dla domu i ogrodu. W naszych marketach pomagamy Klientom w realizacji marzeń o zaprojektowaniu, wybudowaniu i urządzeniu wymarzonego miejsca. Od projektu i listy zakupów, po dekoracyjne dodatki. Wspieramy tworzenie domów, wyposażenie mieszkań, aranżację ogrodów i balkonów, pamiętając jednocześnie, że dom to nie tylko cztery ściany, ale również rodzina, bezpieczeństwo i wygoda. Jeśli chcesz dowiedzieć się więcej na temat naszej firmy to zapraszamy na naszą stronę kariery: https://kariera.obi.pl/
Every company profile is continuously scanned and enriched with actionable sales signals.
Access precise employee headcount tiers, headquarters coordinates, historical founding records, and executive org metadata.
Track seed rounds to Series D+ growth capital, venture syndicate participation, and growth milestones to time high-intent outreach.
Discover exact software dependencies, frontend technologies, cloud hosting providers, and CRM tools powering each organization.